Gil-Bernabe and colleagues found that tumor-derived tissue factor (coagulation factor III or CD142) stimulated clot formation and enhanced subsequent tumor cell survival at the metastatic site by recruiting CD11b+/CD68+/F4/80+/CX3CR1+ macrophages [83]. The gene discussed is ITGAM; the disease is neoplasm.